MERIDIAN BIOSCIENCE INC Quarterly Deferred Income Tax Assets, Net in USD from Q3 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Meridian Bioscience Inc quarterly Deferred Income Tax Assets, Net history and growth rate from Q3 2015 to Q4 2022.
  • Meridian Bioscience Inc Deferred Income Tax Assets, Net for the quarter ending December 31, 2022 was $9.65M, a 9.5% increase year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $9.65M +$837K +9.5% Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $9.28M +$547K +6.27% Sep 30, 2022 10-Q 2023-02-09
Q2 2022 $8.04M -$30K -0.37% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $8.68M +$660K +8.23% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $8.81M +$1.1M +14.2% Dec 31, 2021 10-Q 2022-02-04
Q3 2021 $8.73M +$1.08M +14.2% Sep 30, 2021 10-K 2022-11-22
Q2 2021 $8.07M +$2.37M +41.6% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $8.02M Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $7.71M Dec 31, 2020 10-Q 2021-02-05
Q3 2020 $7.65M +$7.49M +4802% Sep 30, 2020 10-K 2021-11-23
Q2 2020 $5.7M Jun 30, 2020 10-Q 2020-08-07
Q3 2019 $156K Sep 30, 2019 10-K 2020-11-23
Q3 2015 $4.95M Sep 30, 2015 10-K 2016-11-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.